A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

Name: A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany
Published: 2026
License: Public Domain

Novartis Pharmaceuticals · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

adherence c30 germany leukemia mars positive real worldevidence

leukemia, chronic myeloid, asciminib, cml-cp, philadelphia chromosome-positive, real-world evidence, non-interventional study, germany, bcr::abl1, major molecular response, adherence, mars-5, eortc qlq-c30

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 851826
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.